Data / Drug companies / F.i.s. Fabbrica Italiana Sintetici S.p.a.
F.i.s. Fabbrica Italiana Sintetici S.p.a.: 115 products in the FDA NDC directory, labeler code 48087
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
F.i.s. Fabbrica Italiana Sintetici S.p.a. (labeler code 48087) lists 115 products in the FDA National Drug Code Directory. By type: 115 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 13, 2026.
The request: Watch F.i.s. Fabbrica Italiana Sintetici S.p.a. (FDA labeler code 48087): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 48087
- Products in commercial distribution
- 115
- Packages
- 116
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 5, Schedule IV 22
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- December 26, 1990
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 115 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 115 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 115 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lenacapavir sodium | 48087-0172 | Powder | Bulk ingredients | May 13, 2026 |
| Sitagliptin gen1 (inhibited) | 48087-0164 | Powder | Bulk ingredients | October 17, 2025 |
| Doravirine sdi | 48087-0169 | Powder | Bulk ingredients | October 6, 2025 |
| Trofinetide hydrate | 48087-0168 | Powder | Bulk ingredients | March 27, 2025 |
| Tei-6720 | 48087-0162 | Powder | Bulk ingredients | March 25, 2024 |
| Omecamtiv mecarbil | 48087-0167 | Powder | Bulk ingredients | March 12, 2024 |
| Valbenazine ditosylate | 48087-0166 | Powder | Bulk ingredients | September 26, 2023 |
| Olopatadine hydrochloride | 48087-0165 | Powder | Bulk ingredients | September 5, 2023 |
| Ulotaront hydrochloride | 48087-0161 | Powder | Bulk ingredients | November 3, 2022 |
| Erlotinib hydrochloride | 48087-0133 | Powder | Bulk ingredients | September 14, 2022 |
| Trofinetide | 48087-0160 | Powder | Bulk ingredients | July 13, 2022 |
| Estradiol | 48087-0159 | Powder | Bulk ingredients | June 28, 2021 |
| Oxcarbazepine | 48087-0158 | Powder | Bulk ingredients | January 29, 2021 |
| Oxcarbazepine | 48087-0157 | Powder | Bulk ingredients | January 29, 2021 |
| Amg 423 2hcl | 48087-0156 | Powder | Bulk ingredients | December 21, 2020 |
| Sitagliptin phosphate | 48087-0155 | Powder | Bulk ingredients | May 11, 2020 |
| Sitagliptin phosphate | 48087-0154 | Powder | Bulk ingredients | May 11, 2020 |
| Sugammadex | 48087-0153 | Powder | Bulk ingredients | April 2, 2020 |
| Sugammadex | 48087-0151 | Powder | Bulk ingredients | March 5, 2020 |
| Sugammadex crude | 48087-0152 | Powder | Bulk ingredients | March 4, 2020 |
| Sotagliflozin | 48087-0150 | Powder | Bulk ingredients | December 17, 2019 |
| Doravirine sdi | 48087-0145 | Powder | Bulk ingredients | July 11, 2019 |
| Nitrofurantoin | 48087-0148 | Powder | Bulk ingredients | May 14, 2019 |
| Nitrofurantoin | 48087-0147 | Powder | Bulk ingredients | May 14, 2019 |
| Nitrofurantoin | 48087-0146 | Powder | Bulk ingredients | May 14, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.